# Efficacy and Safety of HQGZWWT Patients With Rheumatoid Arthritis

> **NCT03593837** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Cui xuejun** · enrollment: 100 (estimated)

## Conditions studied

- Huang Qi Gui Zhi Wu Wu Granule
- Rheumatoid Arthritis

## Interventions

- **DRUG:** Huang qi gui zhi wu wu granule
- **DRUG:** Huang qi gui zhi wu wu granule placebo

## Key facts

- **NCT ID:** NCT03593837
- **Lead sponsor:** Cui xuejun
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03593837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03593837, "Efficacy and Safety of HQGZWWT Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03593837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*